Oropharyngeal candidiasis: a new treatment option.
Section of Infectious Diseases, University of Arizona, Tucson, Arizona 85724, USA. sklotz@u.arizona.edu
Stephen A
SA
Klotz
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002176:Candida albicans; D002177:Candidiasis / Q000188:drug therapy*; D002180:Candidiasis, Oral / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D010608:Pharyngeal Diseases / Q000188:drug therapy / Q000382:microbiology; D014230:Triazoles / Q000627:therapeutic use*
D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole